Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04511806 · ClinicalTrials.gov registry record
Childhood Cancer Predisposition Study (CCPS)
A clinical trial of Pediatric Cancer, sponsored by Emory University.
- Recruiting
- Registry status
- 1,050
- Enrollment target
- 7
- Study locations
NCT04511806 is a study of Pediatric Cancer that is actively recruiting participants, run by Emory University. The registered enrollment target is 1,050 participants, below the 1,470-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (29% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT04511806, a study of Pediatric Cancer, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- 1,050 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Conditions Studied
Interventions
- OTHER Registry
Study Locations (7)
Georgia
- Children's Healthcare of Atlanta (CHOA) - Atlanta
Massachusetts
- Dana Farber Cancer Institute - Boston
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- St. Jude Children's Research Hospital - Memphis
Texas
- Baylor College of Medicine - Houston
Utah
- Primary Children's Hospital - Salt Lake City
Ontario
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2030-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04511806
The ClinicalTrials.gov registry entry for NCT04511806 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,470-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (29% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.
NCT04511806 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Georgia, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04511806 about?
NCT04511806 is a clinical study titled "Childhood Cancer Predisposition Study (CCPS)". The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h...
What is the current status of trial NCT04511806?
This trial is currently recruiting. The enrollment target is 1,050 participants. The study started on 2021-04-22. Estimated completion is 2030-10.
What conditions does trial NCT04511806 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT04511806?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT04511806?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04511806 being conducted?
This trial has 7 study locations across Georgia, Massachusetts, Pennsylvania, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LIFE Cancer Survivorship Database for Pediatric Cancer
RECRUITING
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
RECRUITING
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
RECRUITING · Phase 1
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.